DPP4 and heart failure: Factors associated with a higher incidence of ACEi-AE include female gender, African American ethnicity, heart failure diagnosis, and concomitant therapy with immunosuppressants or dipeptidyl peptidase-IV (DPP-4) inhibitors [2,5].